Navigation Links
Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25, 2007
Date:10/16/2007

SAN DIEGO, Oct. 16 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced today that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, October 25, 2007 to discuss the Company's third quarter 2007 financial results. A press release reporting Favrille's third quarter 2007 financial results will be issued before the U.S. stock markets open on October 25, 2007.

A live audio webcast of management's presentation will be available on the Investor Relations section of the Company's web site at http://www.favrille.com. Alternatively, callers may participate in the conference call by dialing (866) 578-5788 or (617) 213-8057, passcode 49255440. A telephone replay of the call will also be available for 48 hours. The telephone replay can be accessed by dialing (888) 286-8010 or (617) 801-6888, passcode 47807048.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId(R), is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell non-Hodgkin's lymphoma (NHL) and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.

Company Contact:

Pete De Spain,

Director, Investor Relations

& Corporate Communications

Favrille, Inc.

(858) 526-2426


SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Digital Healthcare Conference 2007: Mounting obstacles for health IT
2. Biomedical engineering conference invites manufacturers
3. Conference to address small town development
4. Wisconsin to host SBIR Conference
5. Gaming conference explores interactive media in learning
6. Digital Healthcare Conference starts on a realistic note
7. Digital Healthcare Conference marks Wisconsins Healthcare IT Week
8. Third coast of biotechnology makes strong showing at VC conference
9. Why companies dont get invited to the DEMO conference
10. Giuliani will keynote RedPrairie Corporations user conference
11. Wicab to present BrainPort at Boston conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...a research industry first, allowing veterinary res...afety study data to be managed in one software app... NJ (PRWEB) November 9, 2009 -- Xybion Medical Sys...™ VM, an integrated enterprise software solu...d care of veterinary research subjects. Pristima&t...
(Date:11/8/2009)... Complete Genomics, a third-generation human genom...of a report in the journal Science describing it...nalysis of sequence data from three complete human...omes sequenced on the proof-of-principle genomic D...to $1,726 for 45x coverage for the samples describ...
(Date:11/6/2009)...tCall/ -- BioSpecifics Technologies Corp. (Nasdaq:...irst-in-class collagenase-based products, today an...r ended September 30, 2009. ,, "We were extrem...,s Arthritis Advisory Committee unanimously recomm...TM) for the treatment of Dupuytren,s disease, and ...
(Date:11/6/2009)...wire/ -- EUCODIS Bioscience, a company,developing,... for the,chemical industry announced today that it...dus, the leading biopharmaceutical company in Lati...Bioscience exclusive access - for the search,of en...ection of,psychrophilic bacteria strains and other...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...in Shipping Dronabinol Soft Gel Capsules Immediate...ical Companies, Inc. (NYSE: PRX ) today announced... Food and Drug Administration for its,Abbreviated ...sion of,Solvay Pharmaceutical,s Marinol(R), a CIII... treat nausea and vomiting associated with cancer,...
...alif., June 30 As most doctors face the,Congressi...s next week,Arcadian Health Plan, Inc. announced t...network physicians at the same level of payment as...o supporting its physician,partners as they contin...,members., Arcadian recognizes the value and qual...
...H, Mass. June 30 Joseph B. Bolen, Ph.D., CSO,of M... Cancer track IBC,Life Sciences Drug Discovery & D...nd Exhibition taking place August 4-7 at the World.... The cancer track presentations will,focus on the...ncers, and,Clinical Biomarkers., Bolen has confir...
Other Biology Technology:Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules 2Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules 3Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics Conference 2
(Date:11/5/2009)... , The National Association of Biology Teachers (...or of biological sciences at Naugatuck Valley Comm...th the 2009 Evolution Education Award during the N...be held 11-14 November 2009 in Denver, Colorado. ,... the American Institute of Biological Sciences,(A...
(Date:11/4/2009)... , Heavy traffic corridors in the cities of Long ...ant proportion of preventable childhood asthma, an...ons on the disease has likely been underestimated,...thern California (USC). , The study, which appe...of Public Health , estimated that nine percent of ...
(Date:11/4/2009)... , PORTOLA VALLEY, Calif., Oct. 19 /PRNewswir...nced molecular sensing and imaging devices which s...today that it has signed exclusive distribution de...and Sensors. The markets covered include Australi...urg (Benelux), Suriname, Italy, France, Spain, Por...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2Illinois Medical District Recognizes Officers of its District Security Group 47860 1Illinois Medical District Recognizes Officers of its District Security Group 47860 2Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 1Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 2Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 1Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 2
...ered that two microRNA (miRNA) molecules help cont...of B-cell chronic lymphocytic leukemia (B-CLL), th...r findings, published in the December 15 issue of ...ing as powerful regulators of gene expression in c... drug treatment, the investigators say. , In t...
...blem could be eliminated simply by dusting slag on...& Industry, the magazine of the SCI. , In the ...f damage annually. , Researcher David Cowen and...t applying slag to wheat growing in greenhouses ha...orporate the silica and express it as spiky struct...
... of plants to defend themselves by accumulating hi...me insects, and that such adaptation potentially e...ites may in turn evolve to deal with high levels o...zabeth Pilon-Smits of Colorado State University an...rnia, Berkeley, appear in the November 21st issue ...
Other Biology News:Pair of microRNA molecules controls major oncogene in most common leukemia 2New moth variety disarms plants guarded by selenium 2
...ystem - dUTP with CyScribe GFX Purification Kit, 5...f Cy3- and Cy5-labeled cDNA.Optimized reagents are...purification.Flexible and optimized protocols can ...her Cy3- or Cy5-labeled nucleotides.Reliable purif...
Canine serum from Equitech-Bio
Rabbit Anti-TOLLIP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
... mA, 100 W maximum.Constant voltage, constant curr...ts in settings and read-outs for precision and rep...tstanding choice for non-IEF ultrathin flatbed gel...Electrophoresis Systems & Standards & Reagents, Po...
Biology Products: